Skip to content

Day-Night Rhythm in Human Skeletal Muscle

Day-night Rhythm in Human Skeletal Muscle Metabolism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02261168
Enrollment
12
Registered
2014-10-10
Start date
2014-11-30
Completion date
2015-07-31
Last updated
2015-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Insulin Resistance

Keywords

Circadian Rhythm

Brief summary

This study evaluates the existence of a day-night rhythm in skeletal muscle energy metabolism in healthy lean subjects. Subjects will stay at the research facility for 44 hours with a standardized living protocol during which several measurements of skeletal muscle and whole body energy metabolism will be performed.

Detailed description

Recent evidence from both observational and experimental studies indicates that disobeying our normal day-night rhythm negatively influences our metabolic and cardiovascular health, possibly leading to obesity and type 2 diabetes mellitus (T2DM). An important hallmark of obesity and T2DM is a decreased skeletal muscle mitochondrial function. Interestingly, recent research indicates that also skeletal muscle mitochondrial function under the influence of a day-night rhythm. The main objective of this study is to investigate the presence of a day-night rhythm in skeletal muscle energy metabolism (in particular mitochondrial function) of healthy young participants. Therefore, subjects will stay at the research unit for 44 hours, with standardized meals and sleeping time. During this period we will take five muscle biopsies, perform indirect calorimetry measurements and blood draws.

Interventions

Subjects stay at the research facility for 44 hours and adhere to a standard sleeping, eating and activity protocol. During this protocol, multiple measurements will be performed including skeletal muscle biopsies (m. vastus lateralis), blood draws, indirect calorimetry and MRS measurements.

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Caucasian * Healthy (as determined by dependent physician based on medical questionnaire) * Male * Age: 18-35 years * Normal BMI (18-25 kg/m2) * Regular sleeping time (normally 7-9h daily)

Exclusion criteria

* Extreme early bird or extreme night person (score ≤30 or ≥70 on MEQ-SA questionnaire) * Heavily varying sleep-wake rhythm * Shiftwork during last 3 months * Travel across \>1 time zone in the last 3 months * Engagement in exercise \> 2 hours total per week * Using \>400mg caffeine daily * Smoking * Unstable body weight (weight gain or loss \> 3kg in the last 3 months) * Significant food allergies/intolerance (seriously hampering study meals) * Participation in another biomedical study within 1 month before the first study visit * Any contra-indication to Magnetic Resonance Imaging (MRI) scanning

Design outcomes

Primary

MeasureTime frameDescription
Day-night rhythm in skeletal muscle mitochondrial respiration40 hours.O2-flux (pmol/mg/s) measured with high resolution respirometry upon administration of different substrates

Secondary

MeasureTime frameDescription
Day-night rhythm in whole-body energy metabolism40 hours.Energy expenditure (kJ/min), glucose oxidation (g/min) and fat oxidation (g/min) measured by indirect calorimetry
Day-night rhythm in muscle DNA, mRNA and protein levels of markers involved in molecular clock and mitochondrial metabolism.40 hours.Quantify mRNA and protein levels by qPCR or micro-array and Western blots
Day-night rhythm of in markers of normal day-night rhythm (cortisol, melatonin, core body temperature)measured during the 2nd study dayBlood cortisol and melatonin levels and core body temperature measured by an ingested telemetric pill.
Day-night rhythm in blood metabolic compounds (e.g. glucose, insulin, FFA's, cholesterol)measured during the 2nd study day
Day-night rhythm of molecular clock mRNA and protein levels in blood PBMC'smeasured during the 2nd study dayMeasured by qPCR and Western Blots
Change in liver volume and liver lipid concentration during the dayFirst study day 6 PM, second study day 7 AMMeasured by Magnetic Resonance Imaging and -Spectroscopy (MRI/MRS). Lipid signals in the MRS spectra will be quantified while suppressing the strong water signal in the region of interest (right liver lobe)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026